Exploring the complex relationship between RIG-I and HER2 in ovarian cancer treatment and drug resistance mechanisms
Discover how Matrix Metalloproteinase 3 (MMP3) contributes to cisplatin resistance in ovarian cancer and the promising new therapeutic approaches.